Stereotactic body radiotherapy was associated with significantly better urinary continence and fewer sexual issues at 2 years ...

Men with localized prostate cancer were randomly assigned to receive either SBRT or control radiotherapy in a phase 3 trial.

In metastatic hormone-sensitive prostate cancer (mHSPC), adding the radioligand 177 Lu-PSMA-617 (Pluvicto) to androgen ...

Prostate cancer is the second leading cause of cancer death among American men. A recent study, conducted by researchers from ...

Prostate cancer poses a significant threat to South African men, especially black men who are at a higher risk. This article ...

Stereotactic body radiotherapy (SBRT) is noninferior to conventional or moderately fractionated radiotherapy for loc ...

Patients with metastatic prostate cancer may have improved survival outcomes after undergoing next-generation PSMA PET ...

Black men with advanced prostate cancer have a greater chance of survival after immunotherapy treatment, at least in part, ...

TULSA is a targeted prostate cancer treatment that uses ultrasound to destroy tumors while preserving healthy tissue.

Prostate cancer is the second leading cause of cancer death among American men. A ground-breaking study, conducted by ...

A ground-breaking study, conducted by researchers from the University of Virginia, Mount Sinai, the University of Michigan, ...

There is a limit of eight, 30-minute appointments. To schedule an appointment, or inquire further, call the hospital’s social ...